Cilo Cybin Holdings (JSE:CCC) PS Ratio: 3.12 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:CCC Cilo Cybin Holdings Ltd JSE:CCC
7 GF Score
Price R0.78
! 1 Warning Sign
View Full Analysis

What is Cilo Cybin Holdings PS Ratio?

Cilo Cybin Holdings JSE:CCC 7 PS Ratio is 3.12 as of Aug. 02, 2026. GuruFocus rates JSE:CCC with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 954 Drug Manufacturers companies, Cilo Cybin Holdings ranks worse than 60.69% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cilo Cybin Holdings's share price is R0.78. Cilo Cybin Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was R0.25. Hence, Cilo Cybin Holdings's PS Ratio for today is 3.12.

The historical rank and industry rank for Cilo Cybin Holdings's PS Ratio or its related term are showing as below:

JSE:CCC' s PS Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 3.12
Current: 3.12

During the past 4 years, Cilo Cybin Holdings's highest PS Ratio was 3.12. The lowest was 0.00. And the median was 0.00.

JSE:CCC's PS Ratio is ranked worse than
60.69% of 954 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs JSE:CCC: 3.12

Cilo Cybin Holdings's Revenue per Sharefor the six months ended in Sep. 2025 was R0.25. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was R0.25.

Back to Basics: PS Ratio


Cilo Cybin Holdings  (JSE:CCC) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Cilo Cybin Holdings PS Ratio Related Terms


Cilo Cybin Holdings PS Ratio Historical Data

* Premium members only.

The historical data trend for Cilo Cybin Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cilo Cybin Holdings PS Ratio Chart

Cilo Cybin Holdings Annual Data
Trend Mar22 Mar23 Mar24 Mar25
PS Ratio
0.00 0.00 0.00 0.00

Cilo Cybin Holdings Semi-Annual Data
Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
PS Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JSE:CCC vs ZTS, UTHR, VTRS: PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cilo Cybin Holdings PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's PS Ratio falls into.


JSE:CCC
7GF Score
Cilo Cybin Holdings Ltd JSE:CCC
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cilo Cybin Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Cilo Cybin Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.78/0.25
=3.12

Cilo Cybin Holdings's Share Price of today is R0.78.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cilo Cybin Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was R0.25.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 3.12 mean?
Cilo Cybin Holdings (JSE:CCC) has a PS Ratio of 3.12 as of Aug. 02, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cilo Cybin Holdings and its competitors. According to the industry distribution chart, Cilo Cybin Holdings ranks #579 out of 954 companies in the Drug Manufacturers industry, placing it in the top 60.7%.
Is Cilo Cybin Holdings' PS Ratio too high?
Cilo Cybin Holdings' current PS Ratio is 3.12. The Drug Manufacturers industry median PS Ratio is 2.28. Cilo Cybin Holdings' value of 3.12 is 36.8% above this industry median. Based on the distribution chart, Cilo Cybin Holdings ranks #579 out of 954 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cilo Cybin Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Cilo Cybin Holdings' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cilo Cybin Holdings ranks #579 out of 954 companies for PS Ratio. This places Cilo Cybin Holdings in the lower half of its industry. The industry median PS Ratio is 2.28. Cilo Cybin Holdings' value of 3.12 is 36.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.28, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cilo Cybin Holdings's current PS Ratio of 3.12 is 36.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cilo Cybin Holdings and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cilo Cybin Holdings's current PS Ratio is 3.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cilo Cybin Holdings stock overvalued right now?
Cilo Cybin Holdings (JSE:CCC) has a current PS Ratio of 3.12. The current PS Ratio is 3.12 and 36.8% above the Drug Manufacturers industry median of 2.28. Cilo Cybin Holdings' overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cilo Cybin Holdings (JSE:CCC), the current PS Ratio is 3.12 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cilo Cybin Holdings Business Description

Address 7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157
Cilo Cybin Holdings Ltd is engaged in identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses. It offers products and services in the medical cannabis sector.
7GF Score

Get the complete analysis for JSE:CCC

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.78
Price